Basic Information | Post buying leads | Suppliers |
Name |
Pyridoxal 5-phosphate monohydrate |
EINECS | 200-208-3 |
CAS No. | 41468-25-1 | Density | N/A |
PSA | 135.99000 | LogP | 0.45310 |
Solubility | 5 g/L (20 °C) in water | Melting Point |
140-143 °C(lit.) |
Formula | C8H12NO7P | Boiling Point | 565.7 °C at 760 mmHg |
Molecular Weight | 265.15 | Flash Point | 296 °C |
Transport Information | N/A | Appearance | pale yellowish white crystalline powder |
Safety | 24/25-36-26 | Risk Codes | 36/37/38 |
Molecular Structure | Hazard Symbols | Xi | |
Synonyms |
3-Hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde monohydrate;3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate monohydrate;Phosphopyridoxal monohydrate;Pyridoxal-5-monophosphoric acid ester monohydrate;UNII-5V5IOJ8338; |
IUPAC Name: (4-Formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate hydrate
Synonyms of 4-Pyridinecarboxaldehyde,3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-, hydrate (1:1) (CAS NO.41468-25-1): 3-Hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde monohydrate ; 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate monohydrate ; Phosphopyridoxal monohydrate ; Pyridoxal-5-monophosphoric acid ester monohydrate ; Pyridoxal-5-phosphate, monohydrate ; Pyridoxyl phosphate monohydrate ; UNII-5V5IOJ8338 ; Pyridoxal, 5-(dihydrogen phosphate), monohydrate
CAS NO: 41468-25-1
Classification Code: Drug / Therapeutic Agent
Molecular Formula: C8H12NO7P
Molecular Weight: 265.1571
Molecular Structure:
Melting Point: 140-143 °C
Product Categories: Biochemistry ; Vitamin Derivatives ; Vitamins
H bond acceptors: 7
H bond donors: 3
Freely Rotating Bonds: 5
Polar Surface Area: 93.76 Å2
Flash Point of 4-Pyridinecarboxaldehyde,3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-, hydrate (1:1) (CAS NO.41468-25-1): 296 °C
Enthalpy of Vaporization: 89.39 kJ/mol
Boiling Point: 565.7 °C at 760 mmHg
Vapour Pressure: 1.23E-13 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LD50 | intramuscular | 250mg/kg (250mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 922, 1961. |
mouse | LD50 | oral | 4640mg/kg (4640mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 922, 1961. |
mouse | LD50 | subcutaneous | 870mg/kg (870mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 922, 1961. |
rat | LD50 | oral | 5900mg/kg (5900mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 922, 1961. |
rat | LD50 | subcutaneous | 850mg/kg (850mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 922, 1961. |
Hazard Codes of 4-Pyridinecarboxaldehyde,3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-, hydrate (1:1) (CAS NO.41468-25-1): Xi
Risk Statements: 36/37/38
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 24/25-36-26
S24/25: Avoid contact with skin and eyes.
S36: Wear suitable protective clothing.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
WGK Germany: 2
RTECS: UV1208000
F: 8-10-23